Edition:
United Kingdom

People: Resverlogix Corp (RVX.TO)

RVX.TO on Toronto Stock Exchange

2.96CAD
22 Jul 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.96
Open
$2.95
Day's High
$2.98
Day's Low
$2.90
Volume
7,372
Avg. Vol
114,338
52-wk High
$4.94
52-wk Low
$2.30

Smith, Eldon 

Dr. Eldon R. Smith, OC, M.D., FRCPC, FCAHS, FAHA, FIACS, is Lead Director of Resverlogix Corp. From 1997 until 2010, Dr. Smith has been Editor-in-Chief of the Canadian Journal of Cardiology and from 1992 to 1997, Dr. Smith was Dean of the Faculty of Medicine at the University of Calgary. Dr. Smith is a director of Canadian Natural Resources Limited, Aston Hill Financial Inc. and IntelliPharmaceuticals International Inc. In 2005, Dr. Smith was made an Officer of the Order of Canada.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --